Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lonza
Biotech
Lonza's Synaffix inks ADC technology pact with Boehringer
Under a new licensing pact, Synaffix will grant Boehringer Ingelheim access to its ADC technologies for an undisclosed number of cancer targets.
Fraiser Kansteiner
Jan 9, 2025 8:00am
BigHat, Synaffix collab outfits AI science with ADC tech
Nov 4, 2024 11:07am
Lonza lands new CEO—Chutes & Ladders
Apr 5, 2024 8:30am
GSK loses R&D leader—Chutes & Ladders
Sep 22, 2023 9:30am
FDA sinks Allarity’s plans for lead oncology asset
Aug 2, 2022 2:41pm
Moderna COVID-19 vax gets FDA panel’s backing despite concerns
Dec 17, 2020 5:58pm
